Analysis of clinical outcomes according to response status in prospective clinical trials of atezolizumab (atezo) in pretreated locally advanced/metastatic urothelial carcinoma (mUC) Meeting Abstract


Authors: Bedke, J.; Merseburger, A. S.; Loriot, Y.; Castellano, D.; Choy, E.; Duran, I.; Rosenberg, J.; Petrylak, D. P.; Dreicer, R.; Perez-Gracia, J. L.; Hoffman-Censits, J. H.; Van Der Heijden, M. S.; Degaonkar, V.; Thiebach, L.; de Ducla, S.; Fear, S.; Powles, T.; Sternberg, C. N.
Abstract Title: Analysis of clinical outcomes according to response status in prospective clinical trials of atezolizumab (atezo) in pretreated locally advanced/metastatic urothelial carcinoma (mUC)
Meeting Title: 2020 Virtuelle Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie (DGHO)
Journal Title: Oncology Research and Treatment
Volume: 43
Issue: Suppl. 4
Meeting Dates: 2020 Oct 9-11
Meeting Location: Virtual
ISSN: 2296-5270
Publisher: S. Karger AG  
Date Published: 2020-10-01
Start Page: 255
End Page: 256
Language: English
ACCESSION: WOS:000575955000577
PROVIDER: wos
DOI: 10.1159/000510995
Notes: Meeting Abstract: 13 -- "2020 Virtual Annual Meeting of the German, Austrian and Swiss Societies for Hematology and Medical Oncology" -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Jonathan Eric Rosenberg
    510 Rosenberg